샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792969

세계의 정맥내 치료 및 정맥 액세스 시장

Intravenous Therapy and Vein Access
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 284 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정맥내 치료 및 정맥 액세스 세계 시장은 2030년까지 316억 달러에 달할 전망

2024년에 261억 달러로 추정되는 정맥내 치료 및 정맥 액세스 세계 시장은 2024년부터 2030년까지 CAGR 3.2%로 성장하여 2030년에는 316억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 투약 용도는 CAGR 2.5%를 기록하며 분석 기간 종료시에는 122억 달러에 달할 것으로 예측됩니다. 혈액제재 용도 분야의 성장률은 분석 기간 동안 CAGR 4.2%로 추정됩니다.

미국 시장은 71억 달러로 추정, 중국은 CAGR 5.9%로 성장할 것으로 예측

미국의 정맥내 치료 및 정맥 액세스 시장은 2024년에 71억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 62억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.9%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.5%로 예측됩니다. 유럽에서는 독일이 CAGR 1.8%로 성장할 것으로 예측됩니다.

세계의 정맥내 치료 및 정맥 액세스 시장 - 주요 동향과 촉진요인 정리

정맥 내 치료와 정맥 접근이 현대 의학의 핵심인 이유는 무엇인가?

정맥 치료와 정맥 접근은 수액, 약물, 영양제, 혈액 제제를 혈류에 직접 빠르고 효율적으로 투여할 수 있게 하여 현대 건강 관리의 기초가 되고 있습니다. 이 투여 방식은 즉각적인 생체 이용률을 제공하기 때문에 중환자 치료, 응급 의료, 수술, 만성질환 관리에 필수적입니다. 항생제 및 화학요법 투여부터 수분 보충 및 전해질 불균형 교정까지 정맥 내(IV) 요법의 다양성은 광범위한 적용을 뒷받침합니다. 병원에서는 급성 질환이나 외상에 대한 1차 치료제로 사용되며, 외래 및 재택의료에서는 암, 자가면역질환, 장기 항균제 치료가 필요한 감염질환 등 장기적인 치료를 지원합니다. 정맥에 대한 접근은 채혈, 진단, 치료적 아페레시스 수행에 필수적이며, 예방 및 치료 의료 모두에 필수적입니다. 당뇨병, 심혈관질환, 신부전증과 같은 생활습관 관련 만성질환의 유병률이 증가함에 따라 신뢰할 수 있는 혈관 접근과 지속적인 정맥 내 치료의 필요성이 크게 증가하고 있습니다. 소아 및 노인 집단에서 특수 정맥 접근 기기는 환자의 안전과 편안함을 향상시키고, 시술로 인한 합병증을 감소시킵니다. 의료 시스템이 효율성과 결과를 점점 더 중요시하는 가운데, 정맥 내 치료는 모든 수준의 치료에서 응급 개입과 구조화된 치료 경로를 모두 지원하는 중요한 임상 도구로 자리매김하고 있습니다.

기술 혁신을 통해 정맥 접근 및 수액 요법의 안전성과 정확성이 어떻게 향상되고 있는가?

기술의 발전은 정확도 향상, 합병증 최소화, 환자 친화적인 시술 실현 등 정맥 내 치료와 정맥 접근에 혁명을 일으키고 있습니다. 가장 주목할 만한 발전 중 하나는 초음파 유도 삽입법의 사용으로, 특히 정맥 접근이 어려운 환자의 첫 번째 성공률을 획기적으로 향상시켰습니다. 적외선 및 근적외선 영상을 이용한 정맥 시각화 장치를 통해 임상의는 반복적인 천자 없이도 최적의 정맥을 찾아내어 불편함과 감염 위험을 줄일 수 있습니다. 투약 오류 감소 소프트웨어와 바코드 스캔 기능을 갖춘 스마트 수액 펌프는 투약 오류를 방지하고 정확한 유량을 보장하는 데 도움이 되는 병원 표준이 되고 있습니다. 카테터 소재는 혈전증 및 카테터 관련 혈류 감염의 위험을 감소시키는 항균 코팅과 생체적합성 폴리머를 포함하도록 진화하고 있습니다. 중심정맥 카테터, 말초 삽입형 중심정맥 카테터(PICC) 및 중앙선 카테터는 현재 다양한 치료 방법과 기간의 특수한 요구 사항을 충족시키기 위해 다양한 구성으로 제공되고 있습니다. 바늘이 없는 커넥터와 폐쇄형 이송 장치도 바늘에 찔리는 손상과 오염의 위험을 줄입니다. 한편, 웨어러블 수액 장치는 외래 및 재택 주입 요법을 가능하게 하여 환자에게 높은 유연성과 편안함을 제공합니다. 전자의무기록과의 통합을 통해 수액 매개변수를 지속적으로 모니터링하고 문서화하여 근거에 기반한 의사결정과 더 나은 임상결과를 지원합니다. 이러한 기술 혁신은 정맥 내 치료의 안전성, 정확성, 그리고 다양한 환자층에 대한 접근성을 향상시키며 정맥 내 치료를 재구성하고 있습니다.

임상 환경과 환자 프로필이 정맥 접근 장비 선택에 어떤 영향을 미칠까?

정맥 내 접근 기기 및 주입 전략의 선택은 임상 환경, 치료 기간 및 개별 환자의 특성과 밀접한 관련이 있습니다. 응급실이나 중환자실에서는 수액이나 약물전달을 위해 말초 정맥 라인을 신속하게 삽입하는 경우가 많으며, 보다 복잡한 치료나 장기적인 치료를 위해 중심정맥 접근을 고려합니다. 수술 환자는 마취 및 수술 후 회복을 위해 단기간의 접근이 필요할 수 있으며, 종양 환자는 불편함을 최소화하면서 항암제 반복 주입을 용이하게 하기 위해 이식형 포트나 PICC 라인이 유용합니다. 신생아나 소아 환자는 정맥의 크기가 작고 민감하기 때문에 특수한 마이크로카테터를 사용하거나 통증을 완화하는 기술이 필요합니다. 낭포성섬유증, 면역부전 환자 등 잦은 수액 주입이나 지속적인 주입이 필요한 만성질환 환자에게는 내구성이 뛰어나고 유지보수가 적은 기기가 우선시됩니다. 환자의 동반 질환도 장치 선택에 영향을 미치며, 감염이나 혈전증 위험이 높은 환자는 항균제나 헤파린 결합 카테터가 필요합니다. 재택의료 환경에서는 임상적 모니터링을 보장하면서 환자의 자립을 지원하는 사용하기 쉬운 휴대용 솔루션이 요구됩니다. 자원이 부족한 환경에서는 숙련된 인력과 장비의 가용성 여부가 더 간단하고 저렴한 옵션을 사용하는 데 영향을 미칠 수 있지만, 전 세계적으로 프로토콜을 표준화하고 의료 종사자가 고급 기술을 습득하도록 하는 노력이 진행되고 있습니다. 임상적 용도와 환자의 다양한 요구는 제품 혁신과 삽입 및 유지 관리 프로토콜의 개선을 지속적으로 촉진하고 있으며, 정맥 내 치료의 광범위한 범위에서 개별 환자 맞춤형 정맥 접근 솔루션의 복잡성과 중요성을 강조하고 있습니다.

정맥내 치료 및 정맥 액세스 세계 시장 확대의 원동력은?

정맥 내 치료 및 정맥 접근 시장의 성장은 인구통계학적 변화, 질병 부담 증가, 의료 서비스의 현대화, 의료기기의 지속적인 발전 등 여러 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 암, 패혈증, 자가면역질환 등 장기간의 집중적인 정맥 내 치료가 필요한 만성질환 및 감염성 질환이 전 세계적으로 증가하고 있다는 점입니다. 특히 선진국에서는 고령화가 진행 중이고, 노인들은 더 자주 입원하거나 복잡한 약물 치료를 필요로 하는 경우가 많기 때문에 이 또한 수요 증가에 기여하고 있습니다. 외래 및 재택의료 서비스가 확대됨에 따라 병원 밖에서도 안전하게 사용할 수 있는 휴대용, 환자 친화적인 수액 기술의 필요성이 증가하고 있습니다. 카테터 설계, 약물전달 시스템, 수액 모니터링의 기술적 향상으로 인해 더 많은 임상의들이 첨단적이고 안전한 수액 솔루션을 채택하고 있습니다. 또한, 병원내 감염을 줄이기 위한 전 세계적인 노력으로 폐쇄형 기기 및 항균 소재의 채택이 확대되고 있습니다. 신흥국에서는 의료 인프라에 대한 투자가 확대되고 정맥 내 치료의 모범 사례에 대한 인식이 높아지면서 새로운 시장이 개척되고 첨단 정맥 접근 기술에 대한 접근성이 확대되고 있습니다. 또한, 교육 프로그램 및 인증 기준을 통해 의료진의 기술 수준이 향상되고, 시술 실수가 감소하며, 환자 예후가 개선되고 있습니다. 또한, 새로운 생물학적 제제나 정맥주사제의 규제 당국의 승인으로 인해 신뢰할 수 있는 수액 전달에 의존하는 치료법이 확대되고 있습니다. 전 세계 의료 시스템이 비용 효율성, 안전성, 환자 중심의 치료에 대한 중요성을 계속 강조함에 따라 정맥 내 치료 및 정맥 접근 시장은 병원과 비병원 환경 모두에서 지속적인 성장을 이룰 준비가 되어 있습니다.

부문

용도(투약 용도, 혈액제재 용도, 영양·완충액 용도, 용적 확장제 용도), 최종 용도(병원 최종 용도, 진료소 최종 용도, 외래 수술 센터 최종 용도)

조사 대상 기업 사례

  • Ajinomoto Health & Nutrition North America, Inc.
  • AngioDynamics, Inc.
  • B. Braun Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company(BD)
  • Cardinal Health
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • CSL Vifor
  • Drip Hydration
  • Fresenius Kabi
  • Haemonetics Corporation
  • ICU Medical, Inc.
  • Medtronic plc
  • Otsuka Pharmaceutical Co., Ltd.
  • Polymedicure
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS
  • Vetter Pharma-Fertigung GmbH & Co. KG

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.25

Global Intravenous Therapy and Vein Access Market to Reach US$31.6 Billion by 2030

The global market for Intravenous Therapy and Vein Access estimated at US$26.1 Billion in the year 2024, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Medication Administration Application, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth in the Blood-based Products Application segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 5.9% CAGR

The Intravenous Therapy and Vein Access market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Intravenous Therapy and Vein Access Market - Key Trends & Drivers Summarized

Why Is Intravenous Therapy and Vein Access a Cornerstone of Modern Clinical Care?

Intravenous therapy and vein access have become fundamental to contemporary healthcare, enabling rapid and efficient administration of fluids, medications, nutrients, and blood products directly into the bloodstream. This mode of delivery offers immediate bioavailability, making it indispensable for critical care, emergency medicine, surgery, and chronic disease management. The versatility of intravenous (IV) therapy supports a wide range of applications, from administering antibiotics and chemotherapy to maintaining hydration and correcting electrolyte imbalances. In hospitals, it is often the first line of intervention for acute illnesses and trauma, while in outpatient and home care settings, it supports long-term treatments for conditions such as cancer, autoimmune diseases, and infections requiring prolonged antimicrobial therapy. Vein access is essential for drawing blood, delivering diagnostics, and performing therapeutic apheresis, making it integral to both preventive and curative care. The growing prevalence of lifestyle-related chronic illnesses, such as diabetes, cardiovascular disease, and kidney failure, has significantly increased the need for reliable vascular access and ongoing IV treatment. In pediatric and geriatric populations, specialized vein access devices improve patient safety and comfort while reducing procedural complications. With healthcare systems increasingly emphasizing efficiency and outcomes, intravenous therapy has established itself as a critical clinical tool, underpinning both emergency interventions and structured treatment pathways across all levels of care.

How Are Innovations Improving the Safety and Precision of Vein Access and Infusion Therapy?

Technological advances are revolutionizing intravenous therapy and vein access by enhancing precision, minimizing complications, and making procedures more patient-friendly. One of the most notable developments is the use of ultrasound-guided insertion techniques, which have dramatically improved first-attempt success rates, especially in patients with difficult venous access. Vein visualization devices using infrared light and near-infrared imaging allow clinicians to identify optimal veins without repeated punctures, reducing discomfort and risk of infection. Smart infusion pumps equipped with dose error reduction software and barcode scanning are becoming standard in hospitals, helping to prevent medication errors and ensure accurate flow rates. Catheter materials have evolved to include antimicrobial coatings and biocompatible polymers that lower the risk of thrombosis and catheter-associated bloodstream infections. Central venous catheters, peripherally inserted central catheters (PICCs), and midline catheters are now available in multiple configurations to meet the specific requirements of different therapies and durations. Needle-free connectors and closed-system transfer devices are also reducing the risk of needle-stick injuries and contamination. Meanwhile, wearable infusion devices are enabling ambulatory and home-based IV therapy, giving patients greater flexibility and comfort. Integration with electronic medical records allows for continuous monitoring and documentation of infusion parameters, supporting evidence-based decision-making and better clinical outcomes. These innovations are collectively reshaping the administration of intravenous therapy by making it safer, more accurate, and more accessible across diverse patient populations.

How Do Clinical Settings and Patient Profiles Influence the Selection of IV Access Devices?

The choice of intravenous access devices and infusion strategies is closely aligned with the clinical setting, duration of therapy, and individual patient characteristics. In emergency rooms and intensive care units, peripheral IV lines are often placed quickly for immediate fluid and drug delivery, with central venous access considered for more complex or long-term treatments. Surgical patients may require short-term access for anesthesia and postoperative recovery, while oncology patients benefit from implantable ports or PICC lines to facilitate repetitive chemotherapy infusions with minimal discomfort. Neonates and pediatric patients present unique challenges due to smaller vein size and increased sensitivity, leading to the use of specialized microcatheters and pain-reduction techniques. For patients with chronic conditions requiring frequent or continuous infusions, such as those with cystic fibrosis or immune deficiencies, durable and low-maintenance devices are prioritized. Patient comorbidities also affect device selection, with those at high risk of infection or thrombosis requiring antimicrobial or heparin-bonded catheters. Home healthcare settings demand user-friendly and portable solutions that support patient independence while ensuring clinical oversight. In resource-limited settings, the availability of skilled personnel and equipment may dictate the use of simpler, lower-cost options, although efforts are being made globally to standardize protocols and train healthcare workers in advanced techniques. The diversity in clinical applications and patient needs continues to drive product innovation and the refinement of insertion and maintenance protocols, underscoring the complexity and importance of tailored vein access solutions within the broader spectrum of intravenous therapy.

What Is Driving the Expansion of the Global Intravenous Therapy and Vein Access Market?

The growth in the intravenous therapy and vein access market is driven by multiple factors rooted in demographic shifts, rising disease burden, healthcare modernization, and ongoing advancements in medical devices. One of the primary drivers is the global increase in chronic and infectious diseases that require prolonged or intensive intravenous treatment, such as cancer, sepsis, and autoimmune disorders. The aging population, particularly in developed countries, is also contributing to increased demand, as older adults often require more frequent hospitalizations and complex medication regimens. The expansion of outpatient and home-based care services is fostering the need for portable and patient-friendly infusion technologies that can be used safely outside hospital settings. Technological improvements in catheter design, drug delivery systems, and infusion monitoring are encouraging more clinicians to adopt sophisticated and safer IV solutions. Additionally, global efforts to reduce hospital-acquired infections are leading to widespread adoption of closed-system devices and antimicrobial materials. In emerging economies, growing investment in healthcare infrastructure and rising awareness of best practices in IV therapy are opening new markets and expanding access to advanced vein access techniques. Training programs and certification standards are also improving practitioner skill levels, reducing procedural errors, and boosting patient outcomes. Furthermore, regulatory approvals for new biologics and intravenous medications are creating a larger pool of therapies that depend on reliable infusion delivery. As healthcare systems worldwide continue to emphasize cost-effectiveness, safety, and patient-centered care, the market for intravenous therapy and vein access is poised for sustained growth across both hospital and non-hospital settings.

SCOPE OF STUDY:

The report analyzes the Intravenous Therapy and Vein Access market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application, Volume Expander Application); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Ajinomoto Health & Nutrition North America, Inc.
  • AngioDynamics, Inc.
  • B. Braun Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Cardinal Health
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • CSL Vifor
  • Drip Hydration
  • Fresenius Kabi
  • Haemonetics Corporation
  • ICU Medical, Inc.
  • Medtronic plc
  • Otsuka Pharmaceutical Co., Ltd.
  • Polymedicure
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS
  • Vetter Pharma-Fertigung GmbH & Co. KG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Intravenous Therapy and Vein Access - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Hospitalization Rates and Chronic Disease Burden Throw the Spotlight on Intravenous Therapy and Vein Access as Clinical Cornerstones
    • Growth in Chemotherapy, Parenteral Nutrition, and Critical Care Propels Demand for Advanced IV Access Devices
    • Here's the Story: Increasing Preference for Minimally Invasive, Long-Dwell Access Strengthens the Business Case for PICCs and Midlines
    • Expansion of Home Infusion Therapy and Outpatient Care Models Drives Demand for User-Friendly, Low-Complication Access Systems
    • Here's How Ultrasound-Guided and Image-Assisted Techniques Are Enhancing First-Attempt Success and Reducing Complications
    • Growing Focus on Infection Prevention and Line-Associated Risks Fuels Innovation in Antimicrobial Catheters and Flush Systems
    • Here's How Needle-Free Connectors and Closed-System Devices Are Improving Safety for Both Patients and Clinicians
    • Aging Population and Rising Surgical Volumes Expand Use of Peripheral and Central Venous Access Devices Across Specialties
    • Technological Advancements in Securement, Dressing, and Stabilization Improve Device Dwell Time and Reduce Dislodgement
    • Growth in Biologic and Specialty Drug Infusion Therapies Spurs Demand for High-Pressure and Power Injectable Access Devices
    • Here's How Real-Time Monitoring and Smart Infusion Systems Are Optimizing Dosing Accuracy and Therapy Compliance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous Therapy and Vein Access Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Medication Administration Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Blood-based Products Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Nutrition & Buffer Solution Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Volume Expander Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제